REGENXBIO Inc.
RGNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$227,102 | -$263,494 | -$280,321 | $127,840 |
| Dep. & Amort. | $16,215 | $17,320 | $12,909 | $9,564 |
| Deferred Tax | $0 | $0 | $0 | -$1,916 |
| Stock-Based Comp. | $38,463 | $40,267 | $40,788 | $38,808 |
| Change in WC | $5,533 | -$10,887 | $13,977 | $40,218 |
| Other Non-Cash | -$6,234 | -$1,613 | $5,159 | $4,361 |
| Operating Cash Flow | -$173,125 | -$218,407 | -$207,488 | $218,875 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,436 | -$9,960 | -$30,724 | -$84,175 |
| Net Acquisitions | $0 | $0 | $0 | -$4,991 |
| Inv. Purchases | -$190,139 | -$86,564 | -$184,875 | -$498,144 |
| Inv. Sales/Matur. | $290,238 | $287,467 | $203,670 | $175,677 |
| Other Inv. Act. | $5,783 | $0 | $0 | $4,991 |
| Investing Cash Flow | $103,446 | $190,943 | -$11,929 | -$406,642 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $131,067 | $6,700 | $1,742 | $218,206 |
| Stock Repurch. | $1,191 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$39,575 | -$41,666 | -$30,582 | -$22,956 |
| Financing Cash Flow | $92,683 | -$34,966 | -$28,840 | $195,250 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $23,004 | -$62,430 | -$248,257 | $7,483 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $36,552 | $98,982 | $347,239 | $339,756 |
| End Cash | $59,556 | $36,552 | $98,982 | $347,239 |
| Free Cash Flow | -$175,561 | -$228,367 | -$238,212 | $134,700 |